MedPath

to compare quality of awakening after anesthesia in patients who recieve normal routine dose versus additional anticonvulsant dose during supratentorial craniotomy.

Phase 4
Conditions
Health Condition 1: G998- Other specified disorders of nervous system in diseases classified elsewhere
Registration Number
CTRI/2023/06/054486
Lead Sponsor
Mahatma Gandhi medical college and hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA physical status I, II, III

Aged 18-60 years scheduled for supratentorial craniotomy for tumor resection

patients who were receiving single anticonvulsant medication for more than one-week duration

Exclusion Criteria

Patient refusal

History of allergy to the study drug

Impaired renal/hepatic function.

Severe left ventricular dysfunction,

Seizures within one week prior to surgery despite the use of antiepileptic drug, patients who were on two anticonvulsants,

Patients with GCS 4 cm associated with midline shift of >5 mm,

surgery lasting longer than 5 hours with >30% blood volume loss

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath